These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1472341)
1. Estimates of HIV infection among injecting drug users in Glasgow, 1985-1990. Frischer M; Green ST; Goldberg DJ; Haw S; Bloor M; McKeganey N; Covell R; Taylor A; Gruer LD; Kennedy D AIDS; 1992 Nov; 6(11):1371-5. PubMed ID: 1472341 [TBL] [Abstract][Full Text] [Related]
2. Estimation of injecting drug users in the City of Edinburgh, Scotland, and number infected with human immunodeficiency virus. Davies AG; Cormack RM; Richardson AM Int J Epidemiol; 1999 Feb; 28(1):117-21. PubMed ID: 10195675 [TBL] [Abstract][Full Text] [Related]
3. Drug injectors in Glasgow: a community at risk? A report from a multidisciplinary group. The Possilpark Group. Health Bull (Edinb); 1993 Nov; 51(6):418-29. PubMed ID: 8307755 [TBL] [Abstract][Full Text] [Related]
4. Estimating the population prevalence of injection drug use and infection with human immunodeficiency virus among injection drug users in Glasgow, Scotland. Frischer M; Leyland A; Cormack R; Goldberg DJ; Bloor M; Green ST; Taylor A; Covell R; McKeganey N; Platt S Am J Epidemiol; 1993 Aug; 138(3):170-81. PubMed ID: 8356960 [TBL] [Abstract][Full Text] [Related]
5. Low and stable prevalence of HIV among drug injectors in Glasgow. Taylor A; Frischer M; Green ST; Goldberg D; McKeganey N; Gruer L Int J STD AIDS; 1994; 5(2):105-7. PubMed ID: 8031910 [TBL] [Abstract][Full Text] [Related]
6. Early mortality of undiagnosed but prevalent (in 1983-1984) HIV infection in Lothian injectors who tested hepatitis B surface antigen positive (group A) or negative but were high risk for blood-borne virus transmission (group B) in 1983-1984. Gore SM; Brettle RP; Burns SM; Lewis SC J Infect; 1998 Sep; 37(2):166-72. PubMed ID: 9821092 [TBL] [Abstract][Full Text] [Related]
7. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group. Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904 [TBL] [Abstract][Full Text] [Related]
8. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow. Rhodes TJ; Bloor MJ; Donoghoe MC; Haw S; Ettore B; Platt S; Frischer M; Hunter GM; Taylor A; Finlay A AIDS Care; 1993; 5(4):413-25. PubMed ID: 8110856 [TBL] [Abstract][Full Text] [Related]
9. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815 [TBL] [Abstract][Full Text] [Related]
10. HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic. Uusküla A; Raag M; Marsh K; Talu A; Vorobjov S; Des Jarlais D PLoS One; 2017; 12(2):e0170956. PubMed ID: 28152026 [TBL] [Abstract][Full Text] [Related]
11. HIV testing and unreported HIV positivity among injecting drug users in London. Donoghoe MC; Rhodes TJ; Hunter GM; Stimson GV AIDS; 1993 Aug; 7(8):1105-11. PubMed ID: 8397948 [TBL] [Abstract][Full Text] [Related]
12. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data. Bird SM; Goldberg DJ; Hutchinson SJ J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088 [TBL] [Abstract][Full Text] [Related]
13. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. Des Jarlais DC; Friedman SR; Perlis T; Chapman TF; Sotheran JL; Paone D; Monterroso E; Neaigus A J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):67-72. PubMed ID: 9928732 [TBL] [Abstract][Full Text] [Related]
14. Mortality among injecting drug users: a critical reappraisal. Frischer M; Bloor M; Goldberg D; Clark J; Green S; McKeganey N J Epidemiol Community Health; 1993 Feb; 47(1):59-63. PubMed ID: 8436897 [TBL] [Abstract][Full Text] [Related]
15. Female streetworking prostitution and HIV infection in Glasgow. McKeganey N; Barnard M; Leyland A; Coote I; Follet E BMJ; 1992 Oct; 305(6857):801-4. PubMed ID: 1422360 [TBL] [Abstract][Full Text] [Related]
16. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Anthony JC; Vlahov D; Nelson KE; Cohn S; Astemborski J; Solomon L Am J Epidemiol; 1991 Nov; 134(10):1175-89. PubMed ID: 1746528 [TBL] [Abstract][Full Text] [Related]
17. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection. Bird SM; Goldberg DJ; Hutchinson SJ J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089 [TBL] [Abstract][Full Text] [Related]
18. Distribution of HIV and acute hepatitis B infection among drug injectors in Glasgow. Gruer LD; Peedle M; Carrington D; Clements GB; Follett EA Int J STD AIDS; 1991; 2(5):356-8. PubMed ID: 1958720 [TBL] [Abstract][Full Text] [Related]
19. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks. Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748 [TBL] [Abstract][Full Text] [Related]
20. HIV prevalence no higher among female drug injectors also involved in prostitution. Rhodes T; Donoghoe M; Hunter G; Stimson GV AIDS Care; 1994; 6(3):269-76. PubMed ID: 7948083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]